Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users
patent: 8 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 44 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Methods for treating pancreatic cancer using combination therapies

Grant US-12364691-B2

United States of America

22 Jul 2025

Combination therapy for cancer treatment

Grant US-11844795-B2

United States of America

19 Dec 2023

Methods for treating pancreatic cancer using combination therapies

Grant US-11369597-B2

United States of America

28 Jun 2022

Methods for treating metastatic pancreatic cancer using combination therapies comprising…

Grant US-11344552-B2

United States of America

31 May 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.